Scottish Enterprise

Scottish Enterprise, established in 1991, is Scotland's principal economic development agency, operating as a non-departmental public body of the Scottish Government. Its mission is to stimulate Scotland's economic growth by fostering an innovative, high-wage, and productive economy with a strong international presence. The agency partners with both public and private sectors to identify and capitalize on opportunities that drive significant, lasting economic impact. Scottish Enterprise provides comprehensive support to businesses, including helping companies secure appropriate finance, strengthening management teams, and facilitating growth and export initiatives. It works closely with Scottish SMEs, as well as UK and international investors, such as business angels, venture capital groups, and corporate investors. The agency operates across Scotland in collaboration with Highlands and Islands Enterprise, aiming to increase the supply of finance for businesses and support the SME funding market.

Reuben Aitken

Managing Director, International Operations

Rhona Allison

Managing Director, Business Growth

Victoria Carmichael

Commercial Director

Mark Hallan

Global Director, Strategic Relationships

Linda Hanna

Managing Director

Jane Martin

Managing Director Of Business Services

Jim McFarlane

Managing Director of Operations

Kerry Sharp

Director of Entrepreneurship and Investment

Charlie Smith

Managing Director of Scottish Development International and Group Head of Strategy and Technology

Susan Armes

Senior Investment Manager

Past deals in Wearables

Neuranics

Grant in 2024
Neuranics is a company focused on developing advanced magnetic sensors integrated with semiconductor technology for applications in health, fitness, and the metaverse. Their proprietary technology is designed to detect minute magnetic impulses produced by the body's organs, utilizing scalable spintronics sensors. This innovative approach aims to address the limitations of current health monitoring devices and enhance human-machine interfaces. By leveraging magnetic sensing, Neuranics seeks to improve the interaction with the central, peripheral, and autonomic nervous systems, as well as muscles, thereby offering significant advancements for healthcare companies in creating next-generation wearable and implantable devices.

Shot Scope

Series B in 2024
Shot Scope Technologies Ltd., established in 2014 and headquartered in Edinburgh, UK, specializes in golf performance tracking technology. The company's flagship product, Shot Scope, is a smart wristband that automatically records and analyzes key performance indicators during golf games. This data helps professional golfers identify areas for improvement, enabling them to make informed decisions on the course and tailor practice sessions effectively. The technology is currently in development, led by a team of engineers and golfers, with trials planned on UK golf courses and a general release scheduled for 2016.

Waire

Venture Round in 2023
Waire Health specializes in the development of wearable vital sign monitoring devices aimed at identifying high-risk patients in hospital wards and at home. By employing advanced artificial intelligence, the company's technology continuously monitors vital signs to detect patterns that may indicate the onset of conditions such as sepsis. This proactive monitoring allows clinicians to receive timely information, facilitating early intervention and improving patient outcomes. By operating autonomously, Waire's solutions help reduce healthcare costs while enhancing the quality of care for patients.

Shot Scope

Series A in 2022
Shot Scope Technologies Ltd., established in 2014 and headquartered in Edinburgh, UK, specializes in golf performance tracking technology. The company's flagship product, Shot Scope, is a smart wristband that automatically records and analyzes key performance indicators during golf games. This data helps professional golfers identify areas for improvement, enabling them to make informed decisions on the course and tailor practice sessions effectively. The technology is currently in development, led by a team of engineers and golfers, with trials planned on UK golf courses and a general release scheduled for 2016.

StretchSense

Series A in 2022
StretchSense specializes in sensor-based technology for capturing hand motion data, focusing on the development of innovative performance capture gloves known as MoCap Pro gloves. These gloves utilize advanced stretch sensor technology, allowing for accurate and comfortable hand tracking. They incorporate soft capacitors that respond to stretching and squeezing, measuring these changes with precision. The gloves work seamlessly with various industry-leading software platforms such as Maya, Unreal Engine, and Unity, as well as with optical systems like OptiTrack, Qualisys, and Vicon. By integrating machine learning with their hardware, StretchSense provides animators, game developers, and film studios with the tools needed for lifelike animations and enhanced performance capture capabilities.

Aiber

Venture Round in 2022
Aiber develops innovative software and medical support systems aimed at enhancing emergency care in challenging environments, such as in the air or at sea. Their solutions leverage Bluetooth sensors to enable wireless monitoring of vital signs, facilitating the identification of patient deterioration or improvement. By providing medical-grade sensors, Aiber empowers crews to manage medical emergencies with confidence and ensures that vital health information is shared with ground-based medical providers. This approach allows flight businesses to deliver consistent and effective care to passengers during flights, supporting international first response efforts on the frontline of emergency care.

Current Health

Series A in 2019
Current Health Limited, founded in 2014 and based in Edinburgh, United Kingdom, specializes in developing wearable healthcare devices that monitor patients' vital signs. These devices are designed to measure key health metrics such as oxygen saturation, respiration rate, pulse rate, temperature, motion, activity, and posture, allowing for the early identification of unwell patients and timely medical intervention. The company also offers a patient monitoring platform that facilitates home-based care by enabling patients to share daily activities, report symptoms, and respond to structured questionnaires for their healthcare providers. By focusing on remote patient management, Current Health aims to reduce healthcare risks and costs while enhancing patient engagement and monitoring. Formerly known as Snap40 Limited, the company rebranded in December 2018 to better reflect its mission.

Current Health

Venture Round in 2019
Current Health Limited, founded in 2014 and based in Edinburgh, United Kingdom, specializes in developing wearable healthcare devices that monitor patients' vital signs. These devices are designed to measure key health metrics such as oxygen saturation, respiration rate, pulse rate, temperature, motion, activity, and posture, allowing for the early identification of unwell patients and timely medical intervention. The company also offers a patient monitoring platform that facilitates home-based care by enabling patients to share daily activities, report symptoms, and respond to structured questionnaires for their healthcare providers. By focusing on remote patient management, Current Health aims to reduce healthcare risks and costs while enhancing patient engagement and monitoring. Formerly known as Snap40 Limited, the company rebranded in December 2018 to better reflect its mission.

Aiber

Grant in 2019
Aiber develops innovative software and medical support systems aimed at enhancing emergency care in challenging environments, such as in the air or at sea. Their solutions leverage Bluetooth sensors to enable wireless monitoring of vital signs, facilitating the identification of patient deterioration or improvement. By providing medical-grade sensors, Aiber empowers crews to manage medical emergencies with confidence and ensures that vital health information is shared with ground-based medical providers. This approach allows flight businesses to deliver consistent and effective care to passengers during flights, supporting international first response efforts on the frontline of emergency care.

Aiber

Seed Round in 2019
Aiber develops innovative software and medical support systems aimed at enhancing emergency care in challenging environments, such as in the air or at sea. Their solutions leverage Bluetooth sensors to enable wireless monitoring of vital signs, facilitating the identification of patient deterioration or improvement. By providing medical-grade sensors, Aiber empowers crews to manage medical emergencies with confidence and ensures that vital health information is shared with ground-based medical providers. This approach allows flight businesses to deliver consistent and effective care to passengers during flights, supporting international first response efforts on the frontline of emergency care.

Shot Scope

Venture Round in 2017
Shot Scope Technologies Ltd., established in 2014 and headquartered in Edinburgh, UK, specializes in golf performance tracking technology. The company's flagship product, Shot Scope, is a smart wristband that automatically records and analyzes key performance indicators during golf games. This data helps professional golfers identify areas for improvement, enabling them to make informed decisions on the course and tailor practice sessions effectively. The technology is currently in development, led by a team of engineers and golfers, with trials planned on UK golf courses and a general release scheduled for 2016.

Pick Protection

Seed Round in 2016
Pick Protection Ltd. specializes in providing security solutions for lone workers, focusing on enhancing safety in various industries such as housing associations, local authorities, retail, facilities management, hospitality, utilities, and financial services. Founded in 2014 and based in Glasgow, the company offers a range of products, including the Personal Guardian self-managed application, the Personal Guardian Monitored Application, and a wearable alarm device. These solutions are designed to ensure accessible, affordable, and reliable protection for employees who work alone, interact with the public, or face environmental hazards. Pick Protection has also partnered with Unipart Security’s NSI Gold Category II Monitored Alarm Receiving Centre to deliver high-standard monitoring services for lone workers.

FINDRA

Seed Round in 2016
FINDRA is a Scottish brand that specializes in high-performance outdoor and adventure clothing for women. The company focuses on designing stylish, versatile, and sustainable apparel made from Italian sports merino wool, which offers natural moisture-wicking properties. FINDRA's mission is to inspire women to embrace an active lifestyle and explore the outdoors without sacrificing performance or style. Operating through an e-commerce platform, the brand aims to encourage consumers to engage in healthy adventures and enhance their well-being.

Shot Scope

Seed Round in 2015
Shot Scope Technologies Ltd., established in 2014 and headquartered in Edinburgh, UK, specializes in golf performance tracking technology. The company's flagship product, Shot Scope, is a smart wristband that automatically records and analyzes key performance indicators during golf games. This data helps professional golfers identify areas for improvement, enabling them to make informed decisions on the course and tailor practice sessions effectively. The technology is currently in development, led by a team of engineers and golfers, with trials planned on UK golf courses and a general release scheduled for 2016.

Ambicare Health

Venture Round in 2010
Ambicare Health Ltd specializes in developing wearable light sources for medical and consumer healthcare applications. The company offers innovative products such as Ambulight PDT, a light-emitting sticking plaster designed for treating non-melanoma skin cancer using photodynamic therapy, which serves as a non-surgical alternative. Additionally, Ambicare Health provides blue light therapy solutions, including Lustre Pure Light Classic and Lustre Pure Light Pro, which are effective in combating spots and acne. These products are distributed through various channels, including online sales and partnerships with distributors. Founded in 2004 and based in Livingston, United Kingdom, Ambicare Health was formerly known as Lumicure Ltd before rebranding in 2009.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.